Search

The load rate of asynchronous motors is low, the operation efficiency is low, and the waste of electric energy is very serious. Therefore, a voltage regulation and electricity saving method for asynchronous motors based on fuzzy control theory is proposed. According to the principle of voltage regulation and power saving of asynchronous motor, the stator current and its variation of are selected as input variables, the deviation of current variation is selected as output variable, and a two-dimensional fuzzy control algorithm model is constructed. Fuzzy control theory is used for voltage regulation and power saving of asynchronous motors. The simulation results show that the proposed method is based on fuzzy control theory for voltage regulation and electricity saving of asynchronous motors; after the voltage regulation and electricity saving control, the phase current of the motor is lower, and the active power and reactive power of the motor are reduced. The power factor of the motor is higher, and the power-saving effect is remarkable.

A continuous‐wave (CW) and passively Q‐switched (PQS) Yb,Ho:LuVO4 laser pumped by a 978.6‐nm laser diode (LD) is demonstrated. The maximum output power of 131 mW at 2059.78 nm in CW regime is achieved with a pump power of 3.01 W, corresponding to a slope efficiency of 10.74%. Under PQS mode operation, an average output power of 45 mW and a shortest pulse width of 100 ns were acquired by a semiconductor saturable absorber mirrors, and for all we know, this is the first report about the PQS Yb,Ho:LuVO4 laser. In addition, a maximum energy per pulse of 12.6 nJ with a pulse repetition frequency of 7.692 MHz was obtained, corresponding to a peak power of 58.5 mW. The beam quality factor was measured to be Mx2 $\,{{\boldsymbol{M}}}_{{\boldsymbol{x}}}^{{\boldsymbol{2}}}$ = 1.10 and My2 ${{\boldsymbol{M}}}_{{\boldsymbol{y}}}^{{\boldsymbol{2}}}$ = 1.10 from the PQS Yb,Ho:LuVO4 laser. [ABSTRACT FROM AUTHOR]

Metabolic syndromes are a group of metabolic disorders for which the molecular mechanisms are still unclear. An increasing number of studies have implicated metabolic syndrome in the association with inflammation. Currently, lipsomes is known to improve nanoparticle hydrophobicity. Meanwhile, in drug delivery systems the application of cholesterol, which is commonly used to stabilise liposomal structures, has essentially no pharmacological effect on liposomes. Herein, we developed an 'anti-inflammatory liposome' (Phy-Lip) to effectively handle these challenges via employing Phytosterol instead of cholesterol. Different with the conventional liposomes, Phy-Lip is a much more brilliant nanoparticle with anti-inflammatory functions. In Phy-Lip, cholesterol was substituted by Phy, which works as membrane stabiliser, anti-inflammatory adjuvant at the same time. The experimental results show that Phy-Lip has a strong anti-inflammatory effect, and improves Metabolic syndromes. This study aims to provide a way to solve the challenge. [ABSTRACT FROM AUTHOR]